COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02416232
Brief Title: Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma

First Submitted : April 9, 2015
First Submitted that Met QC Criteria : April 9, 2015
First Posted : April 14, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 9, 2017
Last Update Posted : August 15, 2017